N-Myc Oncogene Test: Comprehensive Genetic Cancer Analysis
Understanding the N-Myc Oncogene Test
The N-Myc Oncogene Test represents a cutting-edge approach to cancer diagnostics, focusing on one of the most critical genetic markers in oncology. The N-Myc gene, when amplified or overexpressed, serves as a powerful driver of tumor progression and is particularly significant in neuroblastoma and other aggressive cancers. This specialized test provides healthcare providers with essential information for making informed treatment decisions and developing personalized cancer management strategies.
What Does the N-Myc Oncogene Test Measure?
This advanced diagnostic test specifically detects:
- N-Myc gene amplification levels in tumor tissue
- Chromosomal abnormalities affecting the 2p24 region
- Genetic markers indicating aggressive tumor behavior
- Biomarkers that influence treatment response and prognosis
Who Should Consider N-Myc Oncogene Testing?
This test is particularly recommended for individuals with:
- Diagnosed neuroblastoma cases requiring risk stratification
- Suspected aggressive tumor behavior based on clinical presentation
- Family history of cancer syndromes involving Myc gene pathways
- Treatment-resistant cancers requiring additional genetic profiling
- Pediatric cancer cases where N-Myc status impacts treatment decisions
Clinical Indications and Symptoms
Patients presenting with symptoms such as unexplained masses, rapid tumor growth, or poor response to conventional treatments may benefit from N-Myc testing. The test is especially crucial for neuroblastoma patients, where N-Myc amplification status directly influences treatment intensity and prognosis assessment.
Benefits of N-Myc Oncogene Testing
- Accurate Risk Stratification: Provides precise information about tumor aggressiveness
- Personalized Treatment Planning: Guides targeted therapy decisions based on genetic profile
- Prognostic Information: Helps predict disease course and treatment outcomes
- Early Intervention Guidance: Supports timely treatment adjustments
- Comprehensive Cancer Management: Enhances overall treatment strategy development
Understanding Your Test Results
Your N-Myc Oncogene Test results will provide critical information about:
- Amplification Status: Indicates whether N-Myc gene is amplified (increased copy number)
- Risk Assessment: Helps classify cancer as low, intermediate, or high risk
- Treatment Implications: Guides decisions about chemotherapy intensity and duration
- Prognostic Indicators: Provides insights into likely disease progression
It’s essential to discuss your results with your healthcare provider, who can interpret the findings in the context of your specific medical situation and develop an appropriate treatment plan.
Test Details and Pricing
| Test Name | Regular Price | Discount Price | Turnaround Time |
|---|---|---|---|
| N-Myc Oncogene Test | $300 USD | $226 USD | 7-8 Days |
Sample Requirements and Testing Process
The N-Myc Oncogene Test requires:
- Sample Type: Tumor tissue (paraffin embedded tissue blocks)
- Testing Method: FISH (Fluorescence In Situ Hybridization)
- Prescription: Doctor’s prescription required (not applicable for surgery, pregnancy, or travel abroad cases)
Nationwide Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing services nationwide.
Book Your N-Myc Oncogene Test Today
Take control of your cancer management with comprehensive genetic testing. Our experienced team is ready to assist you with scheduling and answer any questions about the testing process.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your N-Myc Oncogene Test and receive your discounted rate of $226 USD.
Early genetic profiling can make a significant difference in cancer treatment outcomes. Don’t wait – contact us now to begin your personalized cancer management journey with advanced genetic insights.
